Export-Friendly Virtual Simulator to Be Displayed by Meggitt Training Systems at Security & Counter Terror Expo
Meggitt Training Systems, the leading provider of integrated live-fire and virtual weapons training products and services for armed forces and law enforcement, will demonstrate its export-friendly FATS® 100MIL small-arms training system at Security & Counter Terror Expo (SCTX). The national security event will be held March 6-7, 2018 at Olympia in London.
Meggitt Training Systems’ FATS 100MIL enabled program-of-record wins for the US Army Engagement Skills Trainer (EST II) and the US Marine Corps Indoor Simulated Marksmanship Trainer (ISMT). Meggitt will demonstrate the system with a variety of weapons, including those based on the company’s BlueFire® wireless technology, the company’s first time exhibiting at SCTX.
“The FATS 100MIL is the result of constant innovation and experience garnered through the delivery and support of 5,100 virtual systems worldwide,” said Mark Mears, European general manager for Meggitt Training Systems. “Customers in the United States, United Kingdom, Italy, Canada, Singapore, Australia, Belgium and elsewhere have chosen Meggitt to fulfill their stringent virtual training requirements.”
The FATS 100MIL is a major expansion in weapons training capability, introducing revolutionary features such as advanced game engine 3D marksmanship, enhanced diagnostics with intelligent automatic coaching and collective training. The new system provides an impressive array of functionality for both instructor and trainee, delivering solid weapon-handling and shot-placement analytics, coaching tools that automatically highlight trainee results for reinforcement or correction, and enhanced graphic capabilities for an all-encompassing immersive training platform.
During the past year, Meggitt has expanded its virtual simulation offerings by introducing the FATS 100P portable training system, featuring full marksmanship and video-based judgmental training capabilities in a compact form factor. It also announced the FATS 300MIL, which provides a five-screen, 300-degree immersive experience for realistic marksmanship, collective and judgmental training. Finally, the company debuted its Live-Fire Screen that brings all the benefits of virtual training to an indoor shooting range or shoot house, thanks to the use of a self-healing rubber screen designed to withstand 50,000 rounds before replacement.
To see a FATS 100MIL demonstration and speak with a Meggitt representative during Security & Counter Terror Expo, visit stand B40 or schedule an appointment at https://meggitttrainingsystems.com/about/request-a-meeting-with-meggitt-training-systems/.
About Meggitt Training Systems
Meggitt Training Systems, makers of FATS® and Caswell technologies, a division of Meggitt PLC, is the leading supplier of integrated live-fire and virtual weapons training systems. Following the acquisition of FATS® virtual training systems and Caswell International’s live-fire ranges and services, Meggitt Training Systems has continued to grow its capabilities based on the legacy of these two industry leaders. Over 13,000 Meggitt live-fire ranges and 5,100 virtual systems are fielded internationally, providing judgmental, situational awareness and marksmanship training to the armed forces, law enforcement and security organizations.
Meggitt Training Systems employs more than 400 people at its headquarters in Atlanta and at facilities in Orlando, Canada, the United Kingdom, Netherlands, UAE, Australia and Singapore. It can deploy service personnel anywhere in the world for instructor training, system installation and maintenance.
About Meggitt PLC
Headquartered in the United Kingdom, Meggitt PLC is an international group operating in North America, Europe and Asia. Known for its specialized extreme environment engineering, Meggitt is a world leader in aerospace, defense and energy, employing nearly 11,000 people at more than 50 manufacturing facilities and regional offices worldwide.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Versum Materials Celebrates the Grand Opening of Its Research and Development Facility in Hometown, PA19.4.2018 20:37 | Pressemelding
Versum Materials, Inc. (NYSE: VSM), a leading materials supplier to the semiconductor industry, announced today the grand opening of its new research and development (R&D) facility at its semiconductor materials manufacturing site in Hometown, Pennsylvania. The ribbon-cutting ceremony took place April 10, 2018. Versum employees, members of the community, local government, customers and strategic partners attended the event. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419006305/en/ Versum Materials ribbon-cutting ceremony at the company's new R&D facility in Hometown, PA. (Photo: Business Wire) The state-of-the-art R&D laboratory is dedicated to new materials used in the manufacture of semiconductors. Scientists in the facility will synthesize and purify new molecules down to parts per billion impurity levels and below using the latest technologies available in the industry. The researchers can assess the applications f
Pharnext to Showcase PLEOTHERAPY™ R&D Platform at the 8th Annual Global Orphan Drug Conference19.4.2018 15:45 | Pressemelding
Regulatory News: Pharnext SA (Paris:ALPHA) (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big data genomics and artificial intelligence, today announced that Rodolphe Hajj, Ph.D., the Company’s Chief Pharmacology Officer, will present at the 8th Annual Global Orphan Drug Conference. The presentation will take place as follows: Date & Time: Wednesday April 25th at 4:40 pm EST Title: “Next generation drug repurposing using network pharmacology to develop new therapeutic entities for rare diseases” Venue: Gaylord National Harbor Hotel, Oxon Hill, MD, U.S. Pharnext’s team will also attend the 2018 American Academy of Neurology Annual Meeting as a first-time exhibitor (booth 908). The meeting will take place on April 21-27, 2018 in Los Angeles, CA, U.S. If you are interested in meeting the Pharnext management team during these events, please send an email to email@example.com. About Pharnext Pharne
New Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best Practices19.4.2018 15:01 | Pressemelding
Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the 2018 Annual Meeting of the Network for the Advancement of Patient Blood Management, Haemostatis and Thrombosis (NATA), in which researchers investigated the utility of Masimo noninvasive and continuous hemoglobin (SpHb®) in supporting and enhancing red blood cell (RBC) transfusion best practices as part of post-operative patient blood management (PBM).1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419005949/en/ Masimo Radical-7® with SpHb® and RD rainbow SET™ Sensor (Photo: Business Wire) In the study, Prof. Baricchi and colleagues in the Transfusion Medicine Unit, AUSL-IRCCS of Reggio Emilia and at the Department of Medicine and Surgery at the University of Parma, Italy, sought to evaluate the appropriateness of post-operative RBC transfusion over a three-year period (2013-2015), before and after implementation of a patient blood managem
Synteract Repositions Itself with Centers of Therapeutic Development and Unveils Updated Brand Platform19.4.2018 14:06 | Pressemelding
Synteract, an innovative contract research organization (CRO) providing full-service, Phase I-IV services to biopharma companies bringing new medicines to market, has enhanced its focus. The CRO today announced the creation of therapeutic centers of development that include some of the most progressive in the biopharma industry: oncology, especially leading edge immunotherapy studies, neuro-degenerative disorders, pediatrics, and rare and orphan disease. In addition, Synteract revealed its new market positioning with an updated logo, tagline, and website to reinforce its core capabilities. Synteract’s leadership has been proven in these core development areas, over its nearly 30-year history, through its contributions to more than 240 product approvals. Formal establishment of its new centers of development bring more visibility to Synteract’s longstanding, specialized expertise in these complex areas of clinical research. Synteract CEO Steve Powell says, “By aligning operational excel
Nel ASA: Receives Additional Purchase Order from Nikola19.4.2018 14:00 | Pressemelding
Nel ASA (Nel, OSE: NEL) has received a USD 5.5 million purchase order from Nikola Motor Company (Nikola), as part of the previously announced hydrogen stations. “We are very proud to announce that we have received an additional order from Nikola related to the electrolyzer and fueling solution for their prototype trucks. The order marks a strengthening of our partnership and is a recognition of the level of competence our team and hydrogen solutions can offer. We look forward to supplying the demo stations, which will lay the groundwork for the world’s largest, most efficient network of low-cost hydrogen production and fueling sites,” says Jon André Løkke, Chief Executive Officer of Nel. On November 15, 2017, Nikola and Nel announced the exclusive partnership and a purchase order for two so-called demo hydrogen refueling stations for Nikola's fleet of prototype hydrogen trucks. The partnership aims at developing low-cost, renewable hydrogen production and fueling sites for the potentia
Voith and Franka Emika Form a Strategic Partnership19.4.2018 13:39 | Pressemelding
The technology company Voith and the Munich-based robotics company Franka Emika have entered into a strategic partnership. Part of the strategic partnership is the establishment of a new joint venture called Voith Robotics – A Voith and Franka Emika Company. The company, with headquarters in Munich, is to become a global system supplier for robot-assisted automation in the digital age. Voith Robotics will offer self-teaching lightweight robots made by Franka Emika, along with software solutions, apps, services and process consulting, to customers in various industries and markets throughout the world. As part of the strategic partnership Voith will also have a direct stake in Franka Emika, thus emphasizing the long-term and strategic commitment by the two companies to cooperation. Martin Scherrer, formerly a member of the Board of Management of Voith Paper, will be the new chief executive officer of Voith Robotics, which is to be managed by Voith. The still very young market for collab